Lightning Talks & More
This is not an official program of the American College of Rheumatology.
All events take place in the Exhibit Hall, Hall F2.
Mystery Diagnosis: Recognizing X-linked Hypophosphatemia (XLH)
Developed and offered by Kyowa Kirin.
Mystery Diagnosis (Continued)
Developed and offered by Kyowa Kirin.
Live Lightning Talk with SetPoint Medical
Developed and offered by SetPoint Medical.
From Camelids to the Clinic: The Potential of Nanobodies® in Rheumatology
Developed and offered by MoonLake Immunotherapeutics.
From Camelids to the Clinic (Continued)
Developed and offered by MoonLake Immunotherapeutics.
Language Matters: Sjögren’s Disease, Not Syndrome
Developed and offered by Sjögren’s Foundation.
A Clinical Approach to Hypophosphatasia
Developed and offered by Alexion.
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Addressing the Heterogeneity of Sjögren’s Disease
Developed and offered by Amgen.
The Clock Is Ticking: A Rheumatologist-Dermatologist Chat on Slowing Structural Damage Progression in Adult Patients With Active PsA
Developed and offered by Johnson & Johnson.
The Next Chapter in CAR T-Cell Therapy: Rapcabtagene Autoleucel Clinical Trials in Autoimmune Diseases
Developed and offered by Novartis.
Descartes-08 Clinical Updates: Expanding BCMA CAR-T Into Rheumatology
Developed and offered by Cartesian.
Clinical Trials Series: Avalyn Pharma
Developed and offered by Avalyn Pharma.
The RESOLUTION Trial: Advancing Autoimmune Treatment with ALLO-329, a Dual-Targeted Allogeneic CAR T Therapy
Developed and offered by Allogene Therapeutics.
From Conception to Delivery: Managing Lupus in Pregnancy
Developed and offered by GSK.
Triple Therapy in Lupus Nephritis: Navigating the Guidelines
Developed and offered by GSK.
FSR’s Initiative to Ensure FMLA Benefits for Clinical Trial Participants
Developed and offered by Foundation for Sarcoidosis Research.
Who We Are: Arcare/ Infinity National Specialty Pharmacy
Developed and offered by Arcare.
Importance of PROs in Real World Evidence-Based Research
Developed and offered by National Databank for Rheumatic Diseases.
Addressing Rheumatology Disparities: Small Volunteer Asks = Big Wins
Developed and offered by ACR Collaborative Initiatives Committee.
Update on Autoimmune Biomarkers
Developed and offered by LabCorp.
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Bridging Evidence and Experience: SAPHNELO® (anifrolumab-fnia) Real-World Patient Case Discussion
Developed and offered by AstraZeneca.